About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Phoenix | 240 Studies

Clinical Trials Alzheimer's DiseasePhoenix

Alzheimer's Disease Clinical Trials in Phoenix

Find 240 clinical trials for alzheimer's disease near Phoenix, Arizona. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 240 trials

CompletedStudy Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With DementiaThis study seeks to evaluate the effect of intepirdine (RVT-101) on gait and balance in patients with Alzheimer's Disease, Dementia with Lewy Bodies or Parkinson's Disease…NCT02910102·Phoenix, Arizona and 10 others CompletedAddressing Dementia Via Agitation-Centered EvaluationThis is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's…NCT03226522·Gilbert, Arizona and 77 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedMetabolic Cerebral Imaging in Incipient Dementia (MCI-ID)A brain PET scan is recognized as "reasonable and necessary" for some patients with "a recently established diagnosis of dementia" (Centers for Medicare and Medicaid Services…NCT00329706·Phoenix, Arizona and 8 others

TerminatedStudy of PRX-03140 Monotherapy in Subjects With Alzheimer's DiseaseA randomized placebo-controlled study to evaluate the efficacy of PRX-03140 monotherapy in subjects with Alzheimer's disease.NCT00693004·Phoenix, Arizona and 32 others

CompletedA Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Alzheimer's Disease.NCT05619692·Gilbert, Arizona and 38 others

Active not recruitingA Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's DiseaseThis is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess safety, tolerability, pharmacokinetics, and efficacy of ONO-2020 in participants with mild to…NCT06881836·Phoenix, Arizona and 79 others

CompletedEfficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to determine the efficacy of ramelteon, once daily (QD), in subjects with mild to moderate Alzheimer's Disease and sleep disturbanceNCT00325728·Alabaster, Alabama and 71 others

CompletedA Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)This is a Phase II, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the safety and efficacy of MABT5102A in patients with mild to moderate…NCT01343966·Phoenix, Arizona and 91 others

TerminatedA Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaThe main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.NCT02783573·Phoenix, Arizona and 261 others

TerminatedLong-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD SubjectsThis study is being conducted to evaluate the long-term safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype.NCT06304883·Phoenix, Arizona and 40 others

CompletedEffects of LY450139, on the Progression of Alzheimer's Disease as Compared With PlaceboAlzheimer's disease (AD) is a fatal degenerative disease of the brain for which there is no cure. AD causes brain cells to die.NCT00762411·Phoenix, Arizona and 90 others

RecruitingA Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses.NCT07602582·Phoenix, Arizona and 58 others

CompletedA Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's DiseaseThis is a randomized double-blind placebo-controlled study comparing different doses of bryostatin for the treatment of moderately severe to severe Alzheimer's disease.NCT02431468·Phoenix, Arizona and 28 others

CompletedAlzheimer's Disease Neuroimaging Initiative 3Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD.NCT02854033·Birmingham, Alabama and 58 others

CompletedFollow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.NCT02795780·Phoenix, Arizona and 21 others

CompletedThe Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's DiseaseMemory loss and difficulties with thinking associated with Alzheimer's disease may be due to chronic release of a brain chemical called glutamate.NCT00090116·Peoria, Arizona and 33 others

Active not recruitingA Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseThe primary objective of the study is to determine the dose response of E2814, when concurrently administered with lecanemab, on the change from baseline at 6 months in…NCT06602258·Phoenix, Arizona and 25 others

CompletedEfficacy and Safety of Aricept in the Treatment of Severe Alzheimer's DiseaseDonepezil hydrochloride (Aricept) has been approved to treat symptoms associated with mild to moderate Alzheimer's disease (AD).NCT00096473·Northport, Alabama and 41 others

Completed18F-AV-1451 High Resolution Autopsy StudyThe study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.NCT02350634·Phoenix, Arizona and 1 other

CompletedThe Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)An urgent need exists to find effective treatments for Alzheimer's disease (AD) that can arrest or reverse the disease at its earliest stages.NCT01767909·Phoenix, Arizona and 24 others

PreviousPage 7 of 12Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia